We are live on ! Find out more
GHCM

Glen Harbor Capital Management Portfolio holdings

AUM $4.82B
1-Year Est. Return 4.69%
This Fund
S&P 500
This Quarter Est. Return
-13.09%
1 Year Est. Return
+4.69%
3 Year Est. Return
+49.45%
5 Year Est. Return
10 Year Est. Return
AUM
$4.14B
AUM Growth
-$839M
Cap. Flow
-$133M
Cap. Flow %
-3.21%
Top 10 Hldgs %
20.73%
Holding
1,388
New
110
Increased
453
Reduced
349
Closed
107

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$27.7M
2
LIN icon
Linde
LIN
+$26.4M
3
CI icon
Cigna
CI
+$25.2M
4
XOM icon
ExxonMobil
XOM
+$23.3M
5
UNP icon
Union Pacific
UNP
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 17%
2 Financials 15.58%
3 Healthcare 14.58%
4 Consumer Discretionary 11.24%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1201
BeOne Medicines Ltd
ONC
$39.2B
$37K ﹤0.01%
+264
New +$35K
GEOS icon
1202
Geospace Technologies
GEOS
$66M
$36K ﹤0.01%
3,476
VET icon
1203
Vermilion Energy
VET
$2.06B
$36K ﹤0.01%
1,672
-418
-20% -$10.9K
GNL icon
1204
Global Net Lease
GNL
$2.08B
$35K ﹤0.01%
+1,980
New +$39.4K
WIX icon
1205
WIX.com
WIX
$3.46B
$35K ﹤0.01%
+392
New +$37K
ICHR icon
1206
Ichor Holdings
ICHR
$1.91B
$32K ﹤0.01%
+1,960
New +$33.9K
WVE icon
1207
Wave Life Sciences
WVE
$879M
$32K ﹤0.01%
+756
New +$33.6K
EVBG
1208
DELISTED
Everbridge, Inc. Common Stock
EVBG
$32K ﹤0.01%
+560
New +$29.1K
SRPT icon
1209
Sarepta Therapeutics
SRPT
$2.19B
$30K ﹤0.01%
+272
New +$34K
TWST icon
1210
Twist Bioscience
TWST
$9.16B
$29K ﹤0.01%
+1,258
New +$27.9K
MNDT
1211
DELISTED
Mandiant, Inc. Common Stock
MNDT
$29K ﹤0.01%
+1,760
New +$31.6K
AA icon
1212
Alcoa
AA
$12.3B
$28K ﹤0.01%
1,056
-46,144
-98% -$1.55M
VTOL icon
1213
Bristow Group
VTOL
$1.25B
$28K ﹤0.01%
1,616
+64
+4% +$1.37K
SBCF icon
1214
Seacoast Banking Corp of Florida
SBCF
$3.32B
$27K ﹤0.01%
1,024
-1,136
-53% -$30.4K
TWLO icon
1215
Twilio
TWLO
$37.2B
$27K ﹤0.01%
+306
New +$24.9K
OBSV
1216
DELISTED
ObsEva SA Ordinary Shares
OBSV
$27K ﹤0.01%
2,142
-1,904
-47% -$28.3K
SENEA icon
1217
Seneca Foods Class A
SENEA
$1.22B
$26K ﹤0.01%
912
CAE icon
1218
CAE Inc
CAE
$7.63B
$25K ﹤0.01%
1,298
-1,188
-48% -$22.6K
DOMO icon
1219
Domo
DOMO
$184M
$25K ﹤0.01%
+1,292
New +$22.8K
KYNB
1220
Kyntra Bio
KYNB
$31.5M
$25K ﹤0.01%
+22
New +$24.7K
ICL icon
1221
ICL Group
ICL
$7.2B
$25K ﹤0.01%
+4,250
New +$25.1K
MEOH icon
1222
Methanex
MEOH
$4.99B
$25K ﹤0.01%
504
-1,540
-75% -$96.1K
TBHC
1223
DELISTED
The Brand House Collective
TBHC
$24K ﹤0.01%
2,492
+224
+10% +$2.17K
AIMT
1224
DELISTED
Aimmune Therapeutics
AIMT
$24K ﹤0.01%
+1,020
New +$26.4K
BHVN
1225
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$24K ﹤0.01%
+656
New +$23.7K

Similar funds

Glen Harbor Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Glen Harbor Capital Management held 1,388 positions worth $4.14B, down 17% from $4.98B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Glen Harbor Capital Management withdrew a net $133M in Q4 2018, closing 107 positions and reducing 349 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $79.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Glen Harbor Capital Management opened a new position in Linde worth $26.1M.

  • Glen Harbor Capital Management's largest Q4 2018 buy was Linde: 167,076 shares worth $26.1M.
  • Glen Harbor Capital Management added most to ConocoPhillips in Q4 2018, an estimated $27.7M increase.
  • Glen Harbor Capital Management's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $25.3M.
  • Glen Harbor Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $79.1M.
  • Glen Harbor Capital Management's ten largest holdings make up 21% of its $4.14B portfolio in Q4 2018.
  • Glen Harbor Capital Management opened 110 new positions and closed 107 in Q4 2018.
  • Glen Harbor Capital Management's portfolio value fell 17% quarter-over-quarter to $4.14B.

Based on Glen Harbor Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.